DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
08 mei 2012 - 07:25
Statutaire naam
DSM B.V.
Titel
DSM reports positive start to the year with robust Q1 results
Bericht
Q1 EBITDA from continuing operations €306 million (Q1 2011: €325 million)
Strong results in Life Sciences due to continued growth in Nutrition
Materials Sciences showed strong improvement compared to Q4 2011
Joint venture with POET established to unlock the advanced biofuels opportunity
Recently announced planned tender offer to acquire Kensey Nash to establish DSM Biomedical as new profitable growth platform
Cautiously optimistic outlook, on the way to achieve 2013 targets
Datum laatste update: 02 september 2024